Expansion Opportunity Oncorus recently expanded its facilities to Andover, Massachusetts, United States, indicating potential demand for products/services in this region. Sales teams can leverage this expansion to target local healthcare institutions and oncology centers for partnership opportunities.
Strategic Partnerships Collaborations with companies like Daewoong Pharmaceutical and expertise in mRNA anti-cancer drugs development present a sales opportunity for Oncorus to offer combined solutions. Sales development teams can explore joint sales strategies and product bundling to tap into a wider market.
Financial Strength With a revenue ranging between $10M - $50M and funding of $20M, Oncorus demonstrates financial stability. This presents a strong selling point for sales professionals to engage potential investors, highlighting the company's growth trajectory and investment potential.
Industry Leadership The appointment of key personnel like a Chief Financial Officer and board members indicates strategic leadership decisions at Oncorus. Sales teams can use this as a credibility factor when approaching potential clients, showcasing the company's strong leadership and vision.
Innovative Technology Oncorus utilizes advanced technologies like mRNA and viral immunotherapies, giving them a competitive edge in the biotechnology research sector. Sales reps can highlight the innovative solutions offered by Oncorus to attract tech-savvy clients looking for cutting-edge cancer treatments.
64
$10M$50M
2$10M
11
293$50M$100M
160$10M$50M
33$10M
112$10M$50M
49$10MOncorus uses 8 technology products and services including WordPress, Microsoft Word, Font Awesome, and more. Explore Oncorus's tech stack below.
| Oncorus Email Formats | Percentage |
| First.Last@oncorus.com | 90% |
| FirstLast@oncorus.com | 5% |
| LastF@oncorus.com | 2% |
| First@oncorus.com | 3% |
Biotechnology ResearchMassachusetts, United States51-200 Employees
Oncorus is focused on realizing the full promise of IV-administered, self-amplifying RNA medicines to transform outcomes for cancer patients. We believe this modality has the potential to safely and effectively kill tumor cells and stimulate multiple arms of the immune system to better fight cancer.
Company Overview
Media & News
Funding & FinancialsOncorus has raised a total of $20M of funding over 5 rounds. Their latest funding round was raised on Apr 05, 2022 in the amount of $20M.
Oncorus's revenue is in the range of $10M$50M
Funding & FinancialsOncorus has raised a total of $20M of funding over 5 rounds. Their latest funding round was raised on Apr 05, 2022 in the amount of $20M.
Oncorus's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com